Rare adverse events that might emerge in large systematic studies could remain invisible in informal self-experimentation
Retatrutide is being studied for weight management and metabolic benefits, with early clinical trials published in the New England Journal of Medicine showing significant results
Public-private partnerships and SouthSouth collaborations are essential to ensure global equity in PD care and innovation
Compounded semaglutide and tirzepatide are both available, but pricing isnt always listed clearly
These drugs can lead to substantial weight loss, especially with tirzepatide, but the likely result is far from uniform, and response may depend on factors medicine still does not fully understand
Despite these shared properties, it is likely that molecular profiles diverge, especially as the paradigm changes